SLOUGH,
United Kingdom and RICHMOND,
Va., Oct. 24, 2024 /PRNewswire/ -- Indivior PLC
(Nasdaq/LSE: INDV) today announced its financial results for the
period ending September 30, 2024. The
earnings release, investor presentation and webcast are available
at www.indivior.com.
- The earnings release can be found at
www.indivior.com/investors
- The investor presentation can be found at
www.indivior.com/investors (at 7:00 am
ET)
There will be a live webcast presentation at 13:00 BST (8:00 am
ET) hosted by Mark Crossley,
CEO. The details are below.
Webcast link: https://edge.media-server.com/mmc/p/ppm4ske8
Participants may access the presentation telephonically by
registering with the following link:
https://register.vevent.com/register/BId4d5b45a6f3e4291ba42150c1620fc64
(Registrants will have an option to be called back directly
immediately prior to the call or be provided a call-in # with a
unique pin code following their registration)
About Indivior
Indivior is a global pharmaceutical company working to help
change patients' lives by developing medicines to treat substance
use disorders (SUD), overdose and serious mental illnesses. Our
vision is that all patients around the world will have access to
evidence-based treatment for the chronic conditions and
co-occurring disorders of SUD. Indivior is dedicated to
transforming SUD from a global human crisis to a recognized and
treated chronic disease. Building on its global portfolio of OUD
treatments, Indivior has a pipeline of product candidates designed
to both expand on its heritage in this category and potentially
address other chronic conditions and co-occurring disorders of SUD.
Headquartered in the United States
in Richmond, VA, Indivior employs
over 1,000 individuals globally and its portfolio of products is
available in over 30 countries worldwide. Visit www.indivior.com to
learn more. Connect with Indivior on LinkedIn by visiting
www.linkedin.com/company/indivior.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/indivior-announces-q3-2024-financial-results-302285061.html
SOURCE Indivior PLC